Taiwan · Delayed Price · Currency is TWD SunWay Biotech Co., LTD. Statistics
Total Valuation
TPEX:1271 has a market cap or net worth of TWD 4.00 billion. The enterprise value is 4.54 billion.
| Market Cap | 4.00B |
| Enterprise Value | 4.54B |
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | Jul 16, 2025 |
Share Statistics
TPEX:1271 has 60.39 million shares outstanding. The number of shares has increased by 20.42% in one year.
| Current Share Class | 60.39M |
| Shares Outstanding | 60.39M |
| Shares Change (YoY) | +20.42% |
| Shares Change (QoQ) | -0.09% |
| Owned by Insiders (%) | 6.90% |
| Owned by Institutions (%) | n/a |
| Float | 28.77M |
Valuation Ratios
The trailing PE ratio is 39.40.
| PE Ratio | 39.40 |
| Forward PE | n/a |
| PS Ratio | 4.02 |
| PB Ratio | 1.22 |
| P/TBV Ratio | 4.52 |
| P/FCF Ratio | 32.97 |
| P/OCF Ratio | 17.94 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.23, with an EV/FCF ratio of 37.41.
| EV / Earnings | 44.68 |
| EV / Sales | 4.57 |
| EV / EBITDA | 23.23 |
| EV / EBIT | 36.44 |
| EV / FCF | 37.41 |
Financial Position
The company has a current ratio of 1.62, with a Debt / Equity ratio of 0.26.
| Current Ratio | 1.62 |
| Quick Ratio | 1.19 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | 4.78 |
| Debt / FCF | 6.90 |
| Interest Coverage | 9.25 |
Financial Efficiency
Return on equity (ROE) is 3.11% and return on invested capital (ROIC) is 2.81%.
| Return on Equity (ROE) | 3.11% |
| Return on Assets (ROA) | 1.58% |
| Return on Invested Capital (ROIC) | 2.81% |
| Return on Capital Employed (ROCE) | 2.62% |
| Weighted Average Cost of Capital (WACC) | 2.92% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.24 |
| Inventory Turnover | 2.16 |
Taxes
In the past 12 months, TPEX:1271 has paid 13.93 million in taxes.
| Income Tax | 13.93M |
| Effective Tax Rate | 12.07% |
Stock Price Statistics
The stock price has increased by +17.55% in the last 52 weeks. The beta is -0.18, so TPEX:1271's price volatility has been lower than the market average.
| Beta (5Y) | -0.18 |
| 52-Week Price Change | +17.55% |
| 50-Day Moving Average | 58.22 |
| 200-Day Moving Average | 64.21 |
| Relative Strength Index (RSI) | 62.70 |
| Average Volume (20 Days) | 103,402 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:1271 had revenue of TWD 993.30 million and earned 101.50 million in profits. Earnings per share was 1.68.
| Revenue | 993.30M |
| Gross Profit | 560.50M |
| Operating Income | 104.13M |
| Pretax Income | 115.42M |
| Net Income | 101.50M |
| EBITDA | 174.89M |
| EBIT | 104.13M |
| Earnings Per Share (EPS) | 1.68 |
Balance Sheet
The company has 301.02 million in cash and 836.01 million in debt, with a net cash position of -534.99 million or -8.86 per share.
| Cash & Cash Equivalents | 301.02M |
| Total Debt | 836.01M |
| Net Cash | -534.99M |
| Net Cash Per Share | -8.86 |
| Equity (Book Value) | 3.26B |
| Book Value Per Share | 53.95 |
| Working Capital | 302.79M |
Cash Flow
In the last 12 months, operating cash flow was 222.89 million and capital expenditures -101.64 million, giving a free cash flow of 121.25 million.
| Operating Cash Flow | 222.89M |
| Capital Expenditures | -101.64M |
| Depreciation & Amortization | 48.11M |
| Net Borrowing | 272.32M |
| Free Cash Flow | 121.25M |
| FCF Per Share | 2.01 |
Margins
Gross margin is 56.43%, with operating and profit margins of 10.48% and 10.22%.
| Gross Margin | 56.43% |
| Operating Margin | 10.48% |
| Pretax Margin | 11.62% |
| Profit Margin | 10.22% |
| EBITDA Margin | 17.61% |
| EBIT Margin | 10.48% |
| FCF Margin | 12.21% |
Dividends & Yields
This stock pays an annual dividend of 1.33, which amounts to a dividend yield of 2.01%.
| Dividend Per Share | 1.33 |
| Dividend Yield | 2.01% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 79.13% |
| Buyback Yield | -20.42% |
| Shareholder Yield | -18.41% |
| Earnings Yield | 2.54% |
| FCF Yield | 3.03% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 9, 2024. It was a forward split with a ratio of 1.0168388514.
| Last Split Date | Dec 9, 2024 |
| Split Type | Forward |
| Split Ratio | 1.0168388514 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |